2006-July Archives by Date

• Messages sorted by: [ thread ] [ subject ] [ author ]
• More info on this list...

Starting: Sat Jul 1 04:36:08 2006
Ending: Mon Jul 31 14:37:04 2006
Messages: 116

• [Ip-health] TWN Info Service: Development meeting begins; FOD Group submits new paper   Sangeeta
• [Ip-health] TWN Info Service:Differences re-emerge on development proposals   Sangeeta
• [Ip-health] TWN Info Service: Continuing differences at WIPO development meeting   Sangeeta
• [Ip-health] IP-Watch: WIPO Development Agenda Talks End With No Agreement For Now   Thiru Balasubramaniam
• [Ip-health] FromGeneva (morning session-1st day of WIPO PCDA): WIPO Development Agenda meeting currently in informal discussions on procedure   Thiru Balasubramaniam
• [Ip-health] AIDS Treatment News on approval and pricing of new protease inhibitor   Mike Palmedo
• [Ip-health] Celgene to Price Cancer Medicine At $6,195 a Month   James Love
• [Ip-health] $6,195 a Month for Celgene's Cancer Drug: Is There a Better Way to Reward Successful Drug Development?   James Love
• [Ip-health] Aidan Hollis comment on prize fund approach   James Love
• [Ip-health] Sangeeta on WIPO: Uncertainty as Development Agenda talks end without result   James Love
• [Ip-health] EU Commission initial findings on Patent policy   Michelle Childs
• [Ip-health] Le Matin (Swiss paper): Soupcons de malversations dans une organisation internationale   Thiru Balasubramaniam
• [Ip-health] Finnish EU Presidency- New Innovation Policy a priority   Michelle Childs
• [Ip-health] AIDS Update: DATA Report: G8 Countries Have Fallen Short on HIV/AIDS, Development Promises Made at 2005 Summit; Kaletra tablet (no need for refrig) approved   Ann-Marie Sevcsik
• [Ip-health] Boy plunges to death after taking controversial 'tamiflu' drug   Chieko Kurihara
• [Ip-health] MSF: ABBOTT PICKS AND CHOOSES WHICH PATIENTS GET CRUCIAL NEW VERSION OF AIDS DRUG   Kate Evans
• [Ip-health] NYT: New AIDS Pill to Treat People in Poor Countries   Amy Nunn
• [Ip-health] Bridges Weekly: WIPO Development Agenda Meeting Breaks down over Chair's text   Thiru Balasubramaniam
• [Ip-health] $6,195 a Month for Celgene's Cancer Drug: Is Ther e a Better Way to Reward Successful Drug Development?   Corey, Beverly F
• [Ip-health] Biolyse succeeds in getting Canadian government to list generic Tamiflu (oseltamivir) for waiver of WTO/Nafta rules on exports of medicines   James Love
• [Ip-health] Wall Street Journal: Global Vaccine Initiative Hits Snag   Thiru Balasubramaniam
• [Ip-health] Robert Goldberg on the Prize of Revlimid   James Love
• [Ip-health] WSJ:Global Vaccine Initiative Hits Snag   Amy Nunn
• [Ip-health] Modeling prize fund rewards   James Love
• [Ip-health] Update on Access Bill at July 13 Brownbag 12-2pm at CPTech   Manon Ress
• [Ip-health] Advance Market Commitments in G8 pre-summit statement   James Love
• [Ip-health] Harvey Bale and Christopher Earl's July 3 FT op-ed on G8 Advance Market Commitment discussions   James Love
• [Ip-health] US-Korea Free Trade Protests in Seoul   robert weissman
• [Ip-health] CPTech comments on the APC/AMC approaches   James Love
• [Ip-health] Bayh Dole Rights, Size of Clinical Trials, 2004 Approvals   Mike Palmedo
• [Ip-health] Bayh Dole Rights, Size of Clinical Trials, 2004 Approvals   Joseph DiMasi
• [Ip-health] European Parliament resolution on HIV/AIDS: Time to Deliver   Alexandra HEUMBER
• [Ip-health] Hankyoreh: Seoul, Washington differ in approach to preliminary free trade talks   Mike Palmedo
• [Ip-health] The Hankyoreh: Bipartisan criticism raised against free trade approach - Government ignoring citizens, groups say   Mike Palmedo
• [Ip-health] Bayh Dole Rights, Size of Clinical Trials, 2004 Approvals   James Love
• [Ip-health] Conceding data exclusivity will damage domestic drug industry - Dr. Joshi   Mike Palmedo
• [Ip-health] Puerto Rico Rx Price Controls   Flynn, Sean M.
• [Ip-health] Bayh Dole Rights, Size of Clinical Trials, 2004 Approvals   Mike Palmedo
• [Ip-health] Bayh Dole Rights, Size of Clinical Trials, 2004 Approvals   Joseph DiMasi
• [Ip-health] FromGeneva: Public Domain & Open Standards discussion at WIPO: What did Mexico, India, Chile and Australia say?   Thiru Balasubramaniam
• [Ip-health] Bloomberg: S Korea Deploys 100,000 Police Against FTA Protesters   Mike Palmedo
• [Ip-health] Korea Herald: Pharmaceuticals Contentious Issue in FTA   Mike Palmedo
• [Ip-health] suspended talks on pharmaceuticals in KORUS FTA   heeseob nam
• [Ip-health] Bayh Dole Rights, Size of Clinical Trials, 2004 Approvals   James Love
• [Ip-health] Reminder Brownbag re FRPAA July 13, 2006 12-2pm   Manon Ress
• [Ip-health] Bayh Dole Rights, Size of Clinical Trials, 2004 Approvals   Joseph DiMasi
• [Ip-health] Korea FTA negotiations on medicines will harm us too   James Love
• [Ip-health] Bayh Dole Rights, Size of Clinical Trials, 2004 Approvals   James Love
• [Ip-health] IP-Watch: Idris's Age Corrected AT WIPO Admidst Speculation Of Benefit-Seeking   Thiru Balasubramaniam
• [Ip-health] CPtech's intervention at EU Patent Hearing 12th July   Michelle Childs
• [Ip-health] Thailand: Bitter Medicine   Stephanie Weinberg
• [Ip-health] Written declaration on international penalties for counterfeiting medicines   Alexandra HEUMBER
• [Ip-health] Viropro and technology transfer for biogenerics   =?iso-8859-1?Q?Marc-Andr=E9_Gagnon?=
• [Ip-health] House International Relations Comm Hearing on Asian FTAs   Mike Palmedo
• [Ip-health] Bayh Dole Rights, Size of Clinical Trials, 2004 Approvals   Joseph DiMasi
• [Ip-health] Initiative for Medicines, Acces & Knowledge Report on TRIPS 39.3 In India   Mike Palmedo
• [Ip-health] Bayh Dole Rights, Size of Clinical Trials, 2004 Approvals   Jon Merz
• [Ip-health] Bayh Dole Rights, Size of Clinical Trials, 2004 Approvals   Joel Lexchin
• [Ip-health] Re: suspended talks on pharmaceuticals in KORUS FTA   heeseob nam
• [Ip-health] Korea FTA negotiations on medicines will harm us too   heeseob nam
• [Ip-health] John Kilama featured in "People" section of IP-Watch   Thiru Balasubramaniam
• [Ip-health] Bayh Dole Rights, Size of Clinical Trials, 2004 Approvals   James Love
• [Ip-health] USTR press release on KORUS FTA   Stephanie Weinberg
• [Ip-health] DNA India: Data exclusivity, a Trojan horse?   Mike Palmedo
• [Ip-health] Size of trials by status (S or P) - Some 2004 FDA and Parexcel data compared   James Love
• [Ip-health] Korea opposition to US/FTA proposals   James Love
• [Ip-health] India/France IPR bilateral agreement   James Love
• [Ip-health] USCIB Committee on Intellectual Property - Recent Accomplishments   James Love
• [Ip-health] G8 statement -- Fight against infectious diseases   James Love
• [Ip-health] IHT, NYT: G-8's drug aid for poor catches an ailment: politics   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] Dong-A Ilbo: FTA Talks Stall on Lack of Compromise   Mike Palmedo
• [Ip-health] Re: India/France IPR bilateral agreement   gerrold@noos.fr
• [Ip-health] Health Versus Wealth: The Thai Frontier   Mike Palmedo
• [Ip-health] balance of patent royalties and licenses   heeseob nam
• [Ip-health] UK model research agreements between business and universities.   Michelle Childs
• [Ip-health] Re: Clients Course Needs Assesment Questionnaire   Taabco
• [Ip-health] Oxfam Urgent Action: Congress Set to Vote on US-Peru Free Trade Agreement   Mike Palmedo
• [Ip-health] Kenya Broadcasting Corp - Coalition Against Change of Patent Act   Mike Palmedo
• [Ip-health] [KoreaHerald] Seoul reaffirms FTA stance   heeseob nam
• [Ip-health] Times of India: Firms ready with cheaper AIDS drugs   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] Statement on 2nd round of KORUS FTA   heeseob nam
• [Ip-health] Wall Street Journal: Gates Won't Fund AIDS Researchers Unless They Pool Data   Thiru Balasubramaniam
• [Ip-health] Forbes: String Attached: Gates AIDS Gift Requires Collaboration   Mike Palmedo
• [Ip-health] FTC Testifies on Barriers to the Entry of Generic Drugs   Mike Palmedo
• [Ip-health] U.S. government pushed Korea to drop new drug policy   heeseob nam
• [Ip-health] The Lancet: Is access to essential medicines as part of the fulfilment of the right to health enforceable through the courts?   Ira Glazer
• [Ip-health] Kenyan activists: "Patents over patients, we need your support in protesting"   Asia Russell
• [Ip-health] Aidan Hollis: Off-label prescribing and rewards based on observed value   James Love
• [Ip-health] Copying the generics: FDA OKs new 1-a-day dose of 3-drug combination to fight AIDS   Ira Glazer
• [Ip-health] IP-Watch: WHO IP Working Group To Address Conflicting Interests Before December Meeting   Thiru Balasubramaniam
• [Ip-health] EU Com McCreevy's future of patent policy speech   Michelle Childs
• [Ip-health] A Korea-U.S. trade agreement: what is at stake? - Dean Baker   Dan Beeton
• [Ip-health] MOHW Proposes Reformation Bill for Drug Costs   heeseob nam
• [Ip-health] Kenyan civil society statement: OUR LIVES OVER PATENT RIGHTS!!   Mike Palmedo
• [Ip-health] E. African Standard: Kenyan Change in Patent Law to Raise Cost of Drugs by 300 Percent   Mike Palmedo
• [Ip-health] E. African Standard: Kenyan Change in Patent Law to Raise Cost of Drugs by 300 Percent   =?ISO-8859-1?Q?Ga=EBlle_Krikorian?=
• [Ip-health] GSK announces avian flu vaccine breakthrough   Ira Glazer
• [Ip-health] Biosimilar drugs   Dolores Cullen
• [Ip-health] Copying the generics: FDA OKs new 1-a-day dose of 3-drug combination to fight AIDS   Hember, Miles
• [Ip-health] Size of trials by status (S or P) - Some 2004 FDA and Parexcel data compared   Joseph DiMasi
• [Ip-health] Bridges Weekly: US-KOREA FTA TALKS END EARLY AMIDST DISAGREEMENT   Thiru Balasubramaniam
• [Ip-health] PhRMA statement on Korean drug pricing policy   heeseob nam
• [Ip-health] Salon: "Biosimilar," but not identical   Thiru Balasubramaniam
• [Ip-health] Patent Oppositions Filed on 3 Essential Drugs   chan park
• [Ip-health] Forum for Health Economics and Policy - recently posted articles   James Love
• [Ip-health] Salon: "Biosimilar," but not identical   Hember, Miles
• [Ip-health] Salon: "Biosimilar," but not identical   Dolores Cullen
• [Ip-health] Cancer care can sap a lifetime of savings   Joana Ramos
• [Ip-health] Wall Street Journal: FBI Raids Offices At Bristol-Myers Over Plavix Deal   Thiru Balasubramaniam
• [Ip-health] Drug Makers Pay for Lunch as They Pitch   James Love
• [Ip-health] Government website on Canadian law on compulsory licensing of pharmaceuticals for export   Richard Elliott
• [Ip-health] Size of trials by status (S or P) - Some 2004 FDA and Parexcel data compared   James Love
• [Ip-health] Wall Street Journal: At a Crossroads: Failed Trade Talks Cloud WTO's Future   Thiru Balasubramaniam
• [Ip-health] =?iso-8859-1?Q?NOUVELLE_PUBLICATION:_Gu=EDa_Pr=E1ctica_sobre_la_OMC_-_NEW?= =?iso-8859-1?Q?_PUBLICATION:_Gu=EDa_Pr=E1ctica_sobre_la_OMC__________18?=   3D -> Trade - Human Rights - Equitable Economy
• Fwd: [Ip-health] E. African Standard: Kenyan Change in Patent Law to Raise Cost of Drugs by 300 Percent   Gaelle Krikorian
• [Ip-health] Kenya: Reprieve As Karua Acts to Keep Aids Drugs Cheap   Mike Palmedo

Last message date: Mon Jul 31 14:37:04 2006
Archived on: Mon Jul 31 13:37:05 2006

• Messages sorted by: [ thread ] [ subject ] [ author ]
• More info on this list...